SCHEMBL7138352

SCHEMBL7138352

C=CCOc1cc(N)c([N+](=O)[O-])cc1I

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.40
ALDH1A1 P00352 5/20 0.39
TDP1 Q9NUW8 4/20 0.39
TSHR P16473 2/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39
LMNA P02545 2/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
POLB P06746 2/20 0.36
MCL1 Q07820 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8536873 0.83 MAPT (0.43) MAPTALDH1A1TDP1TSHRCYP3A4
SCHEMBL7139766 0.77 ALDH1A1 (0.51) MAPTALDH1A1TSHRLMNAMEN1
SCHEMBL6167738 0.77 MAPT (0.46) MAPTALDH1A1TDP1TSHRCYP3A4
SCHEMBL28338065 0.76 CYP3A4 (0.40) MAPTALDH1A1TDP1TSHRCYP3A4
SCHEMBL7141939 0.75 HTT (0.49) MAPTALDH1A1TDP1TSHRCYP3A4
SCHEMBL5642200 0.74 ALDH1A1 (0.49) MAPTALDH1A1TDP1TSHRCYP3A4
SCHEMBL7139665 0.74 ALDH1A1 (0.48) MAPTALDH1A1TDP1CYP3A4LMNA
SCHEMBL7143140 0.74 MAPT (0.43) MAPTALDH1A1TDP1TSHRCYP3A4
SCHEMBL28691830 0.74 TSHR (0.43) MAPTALDH1A1TSHRCYP3A4LMNA
SCHEMBL169638 0.74 MAPT (0.66) MAPTALDH1A1TDP1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1195522-C Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist HOFFMANN LA ROCHE (CH) 2005-04-06 CN disclosed
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
CN-1379765-A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist HOFFMANN LA ROCHE (CH) 2002-11-13 CN disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed